IP Library Assignment 055321/0877
Patent Assignment
Reel/Frame 055321/0877

Merger

Recorded: 2021-02-18 Pages: 6
Assignor
Assignee
NANGENEX NANOTECHNOLOGY INCORPORATED
MADARÁSZ VIKTOR UTCA 47-49., BUDAPEST, 1138, HUNGARY
Covered Property (1)
Pharmaceutical Formulation Containing Tadalafil
Application: 15/827,417 →
Publication: US 2018/0161325
Related Assignments (2)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Apr 19, 2018
From: SZABÓNÉ ORDASI, BETTI; JORDÁN, TAMÁS; KÁRPÁTI, RICHÁRD BALÁZS; UJHELYI, ANDREA
To: DRUGGABILITY TECHNOLOGIES IP HOLDCO LIMITED
Reel/Frame 045592/0879 →
Change of Name Feb 18, 2021
From: NANGENEX NANOTECHNOLOGY INCORPORATED
To: TAVANTA THERAPEUTICS HUNGARY INCORPORATED
Reel/Frame 055322/0045 →